Jump to navigation

DiaSorin Group
DiaSorin Immunodiagnostic
DiaSorin Molecular
Luminex
GROUP WEBSITES
Home
  • Group
  • Sustainability
  • Governance
  • Investors
  • Media
  • People
  • Italiano Italiano
  • English English
Home / Investors / Financial corner / Press releases / DiaSorin launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease

DiaSorin launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease

Mon, 07/17/2023 - 07:03
pdfDownload press release510.4KB
follow us
tools
Share
DiaSorin ImmunodiagnosticDiaSorin MolecularLuminex
Legal NoticesPrivacy PolicyModern Slavery Statement

DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729
Fiscal Code and Subscription to Vercelli Companies Register no 13144290155

Headquarter
via Crescentino SNC, 13040 Saluggia (VC)
tel. +39 0161 487.1

Home
    • Group
      • About Us
      • Knowledge is key
      • Our history
      • Our People
      • Business Model
    • Sustainability
      • Our commitment
      • NFD 2022
      • Sustainability projects
      • Fondazione DiaSorin
      • Reports and non-financial statements
    • Governance
    • Mandatory Financial Disclosures
      • Governance documents
        • By-Laws
        • Procedures
        • Code of Ethics and Model 231
        • Reports on Corporate Governance
      • Corporate bodies
      • Shareholder's Meeting
      • Remuneration
        • Reports on remuneration
        • Information Documents Incentive Plans
      • Internal Dealing operations
      • Buy back program
      • Ownership structure
        • Total shareholders' basis
        • Loyalty shares
    • Investors
      • Investor Day 2021
      • Business development
        • Projects
        • Luminex acquisition
        • COVID-19 | Updates
      • Stock price
      • Financial corner
        • Results
        • Press releases
        • Presentations
        • Annual & Interim Reports
        • 2022 Report
        • Bond
      • Consolidated data
        • Interactive KPI
      • Coverage
      • Information documents
      • Calendar
      • Keep in touch
      • Stock market indices and trading codes
    • Media
      • Press releases
      • Image Gallery
        • Top Management
        • Research laboratory
        • Corporate
      • Video gallery
        • Group
        • Events
        • People
      • Social Wall
      • Press kit
    • People
      • Meet our People
      • People Strategy
      • Talents4LIFE
      • Work with us